U.S. Markets close in 4 hrs, 30 mins
| Symbol | Value | Change | Percentage Change |
|---|---|---|---|
| DJIA | 10,021.00 | -37.64 | -0.37% |
| NASDAQ | 2,139.94 | -10.93 | -0.51% |
| S&P 500 | 1,065.75 | -4.77 | -0.45% |
Experience real-time quotes &
news with the most powerful
iPhone application for investors.
Get the FREE DailyFinance iPhone application
| Day Low | 19.06 10:17 AM EST | |
|---|---|---|
| Day High | 19.24 09:35 AM EST |
|
| Range | 0.18 |
| Volume | 48,633 | |
|---|---|---|
| 30-Day Avg Vol | 109,000 |
|
| Difference | -55.38% |
| Market Cap | 1.27 B | |
|---|---|---|
| Mkt Cap Chg | -29.97 M |
| Shares Out | 66.60 M | |
|---|---|---|
| % Shrs Traded | 0.07% | |
| 1yr EPS Est | 0.623 |
| 52-Wk Low | 17.50 | |
|---|---|---|
| 52-Wk High | 25.53 |
|
| Range | 8.03 |
| Prev Close | 19.59 2/9/10 | |
|---|---|---|
| Today's Open | 19.14 | |
| Change | -2.30% |
| Dividend (TTM) | 0.00 | |
|---|---|---|
| Div Yield (TTM) | 0.00% | |
| Ex-Div Date | — | |
| Div Date | — |
|
| Short Interest | 545,703.00 |
| Revenue (LFY) | 392.58 M | |
|---|---|---|
| Earnings (LFY) | 21.43 M | |
| Earnings (MRQ) | 14.43 M | |
| Next Earn Est | 0.12 | |
| Next Earnings | 11/09/2010 |
|
| EPS (TTM) | 0.56939 | |
| 1yr EPS Growth | 58.52% |
| P/E Ratio (TTM) | — | |
|---|---|---|
| P/E Ratio (Fwd) | 30.00 | |
| PEG Ratio | 1.94 | |
| Return on Equity | 3.32 | |
| Beta | 0.67 |
| Sector | Healthcare | |
|---|---|---|
| Industry | Drugs |
above for more info
Crucell wants to play a crucial role in drug development. The biotech firm develops, produces, and markets vaccines and antibodies to prevent and treat infectious diseases. The company currently markets ... View Full Description
| Earnings/Share(EPS) | Estimate | Actual | Difference |
|---|---|---|---|
| Next Quarter | 0.12 2/9/10 | — — |
—
—
|
| Last Quarter | 0.145 9/30/09 | 0.15 9/30/09 |
0.005
Beat
|
| 2 Quarters Ago | 0.045 6/30/09 | -0.03 6/30/09 |
-0.075
Missed
|
| Quarterly - 09/30/2009 | Annual - 2008 | |
|---|---|---|
| Total Revenue | 129.48 M | 392.59 M |
| Gross Profit | 50.04 M | 151.73 M |
| Operating Income | 4.29 M | -19.36 M |
| Net Income | 14.43 M | 21.43 M |
Notices and Terms: Confirm all data with your broker before trading.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Quote data provided by Interactive Data. Real-Time prices provided by BATS. Historical prices provided by Prophet. Company Profile provided by Hoovers. Executive data and Industry/Sector information provided by Morningstar Inc. Earnings, Ownership, Financial Statement, Insider Trading, Conference Call schedules and SEC Filing information provided by Thomson Reuters.
Advanced Chart
Technical Charts